comparemela.com

Latest Breaking News On - Debjit chattopadhyay - Page 1 : comparemela.com

Intellia Therapeutics, Inc (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript

Intellia Therapeutics, Inc (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesYanan zhuDebjit chattopadhyayKostas biliourisLaura sepp lorenzinoIan karpGlenn goddardJohn leonardDavid lebwohlBrian chengTroy langfordMaury raycroftGina wangBenazir aliDrug administrationCorporate communications at intellia

Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript

VRTX earnings call for the period ending March 31, 2024.

New zealandUnited statesSalveen richterColin bristowTerence flynn morgan stanleyLiisa baykoSalveen richter goldman sachsOlivia brayer cantor fitzgeraldSusie lisaDebjit chattopadhyayStuart arbuckleGeoff meachamAmerica merrill lynchOlivia brayerJessica fyeReshma kewalramani

Krystal Biotech, Inc (NASDAQ:KRYS) Q4 2023 Earnings Call Transcript

Operator: Thank you for standing by and welcome to the Krystal Biotech Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are on a lesson-only mode.

United statesTim lugoGavin clark gartnerChristine wilsonAlec stranahanDebjit chattopadhyayJoe pantginisSuma krishnanKrish krishnanKate romanoWilliam blairKrystal biotech incEuropean medical agencyGoldman sachsCystic fibrosis foundationMost valuable tobacco companies

Krystal Biotech Analysts Increase Their Forecasts Following Q4 Results - Krystal Biotech (NASDAQ:KRYS)

Krystal Biotech, Inc. (NASDAQ: KRYS) reported better-than-expected financial results for its fourth quarter on Monday.

Debjit chattopadhyayYigal nochomovitzKrishs krishnanKrystal biotech incKrystal biotech

Why Soleno Therapeutics Stock Ticked Higher on Thursday

The latest pundit take on the stock provided a good reason for bulls to snap it up.

Debjit chattopadhyayDrug administrationSoleno therapeuticsDiazoxide cholinePrader willi syndromeNew drug applicationMotley fool stock advisorStock advisor

vimarsana © 2020. All Rights Reserved.